“Production of Lentivirus Particles Pseudotyped With SARS-CoV-2 Spike Protein for Neutralisation or Drug Antiviral Activity Assays”. 2023. One Health & Risk Management , December, 77. https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/657.